US Patent Issued to SHANGHAI SHENGDI PHARMACEUTICAL, SHANGHAI SENHUI MEDICINE, Jiangsu Hengrui Medicine on Sept. 23 for "Neurokinin-1 antagonist" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,260, issued on Sept. 23, was assigned to SHANGHAI SHENGDI PHARMACEUTICAL Co. LTD (Shanghai), SHANGHAI SENHUI MEDICINE Co. LTD. (Shanghai) and Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China).

"Neurokinin-1 antagonist" was invented by Jian Huang (Shanghai), Lingjian Zhu (Shanghai), Yang Zou (Shanghai) and Yinggang Tang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound represented by formula II or a pharmaceutically acceptable salt thereof, and a preparation method therefor. The compound represented by formula II is an antagonist of a neurokinin-1 receptor, can be used for treating diseases related to the neurokinin-1 receptor...